Global End Stage Renal Disease Market Grew at Significant CAGR, Says Daedal Research in Its New Report Available at

30 Jun 2016 • by Natalie Aster

LONDON – The global market for end stage renal disease (ESRD) grew at a high rate over the last several years, and its upsurge can be attributed to such factors as growth in ageing population, an increase in healthcare per capita expenditure, rising demand across emerging markets (e.g. China, Brazil and India), and more.

Relatively low public awareness and adverse societal effects are some of major challenges this marketplace faces.

Higher life expectancy of ESRD patients and relationship between ESRD treatment and mortality are amongst key market trends.

North America, EMEA, Latin America and APAC are the largest player on a regional level.

The global marketplace is set to experience growth in the upcoming years, and factors mentioned above will support it.

New research report “Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)” developed by Daedal Research offers a detailed guide to the world’s ESRD marketplace. The study starts with insightful coverage of the disease. It estimates ESRD prevalence rate and a volume of this market.

The report focuses on the kidney transplant marketplace and pays special attention to major countries. The research study analyzes the dialysis market and throws light on key regions as well as countries. It also scrutinizes home dialysis marketplace, too.

The research report casts light on dynamics of the global market and the competitive landscape. The study pays attention not only to largest world’s players, but also to the largest regional players. Future outlook for this marketplace is on hand in the report, as well.

Other Marketplaces Explored by the Publisher Include:

More new studies by Daedal Research can be found at its page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970